about
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast...
Read More
1.61
0.03
(1.90%)
765.0K
XNAS Volume
XNAS 11 Jul, 2025 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Macrogenics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..